The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The relationship between frailty and polypharmacy in older people: A systematic review
Open accessAbstract
Aims: Frailty is a complex geriatric syndrome resulting in decreased physiological reserves. Frailty and polypharmacy are common in older adults and the focus of extensive studies, although little is known about the impact they may have on each other. This is the first systematic review analysing the available evidence on the relationship between frailty and polypharmacy in older adults. Methods: Systematic review of quantitative studies. A comprehensive literature search for publications in English or Spanish was performed on MEDLINE, CINAHL, the Cochrane Database and PsycINFO in September 2017 without applying restrictions on the date of publication. Studies reporting any relationship between frailty and polypharmacy in older adults were considered. Results: A total of 25 publications were included, all of them observational studies. Evaluation of Fried's frailty criteria was the most common approach, followed by the Edmonton Frail Scale and FRAIL scale. Sixteen of 18 cross‐sectional analyses and five of seven longitudinal analyses demonstrated a significant association between an increased number of medications and frailty. The causal relationship is unclear and appears to be bidirectional. Our analysis of published data suggests that polypharmacy could be a major contributor to the development of frailty. Conclusions: A reduction of polypharmacy could be a cautious strategy to prevent and manage frailty. Further research is needed to confirm the possible benefits of reducing polypharmacy in the development, reversion or delay of frailty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
Frailty Consensus: A Call to Action
Morley, J. E., Vellas, B., Abellan van Kan, G., Anker, S. D., Bauer, J. M., Bernabei, R., Cesari, M., Chumlea, W. C., Doehner, W., Evans, J., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.022 · Cited by 4,043
Self-citationWhat is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Frailty in relation to the accumulation of deficits
Rockwood, K., & Mitnitski, A. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.7.722 · Cited by 3,076
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group
Furlan, A. D., Pennick, V., Bombardier, C., & van Tulder, M. (2009) · Spine · doi:10.1097/brs.0b013e3181b1c99f · Cited by 1,663
Herzog, R., Álvarez-Pasquin, M. J., Díaz, C., Del Barrio, J. L., Estrada, J. M., & Gil, Á. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-154 · Cited by 1,652
Harding, S. D., Sharman, J. L., Faccenda, E., Southan, C., Pawson, A. J., Ireland, S., Gray, A. J. G., Bruce, L., Alexander, S. P. H., Anderton, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1121 · Cited by 1,646
Williamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., Fine, L. J., Haley, W. E., Hawfield, A. T., Ix, J. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.7050 · Cited by 1,261
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13877 · Cited by 597
Jyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
Jokanovic, N., Tan, E. C. K., Dooley, M. J., Kirkpatrick, C. M., & Bell, J. S. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.003 · Cited by 415
Frailty Screening in the Community Using the FRAIL Scale
Woo, J., Yu, R., Wong, M., Yeung, F., Wong, M., & Lum, C. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.01.087 · Cited by 374
The Effects of Polypharmacy in Older Adults
Hilmer, S., & Gnjidic, D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.224 · Cited by 362
Polypharmacy Status as an Indicator of Mortality in an Elderly Population
Jyrkkä, J., Enlund, H., Korhonen, M. J., Sulkava, R., & Hartikainen, S. (2009) · Drugs & Aging · doi:10.2165/11319530-000000000-00000 · Cited by 346
Warwick, J., Falaschetti, E., Rockwood, K., Mitnitski, A., Thijs, L., Beckett, N., Bulpitt, C., & Peters, R. (2015) · BMC Medicine · doi:10.1186/s12916-015-0328-1 · Cited by 329
High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V, Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Le Couteur, D. G. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.258 · Cited by 303
Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care
Castell, M.-V., Sánchez, M., Julián, R., Queipo, R., Martín, S., & Otero, Á. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-86 · Cited by 297
Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
Alshabanat, A., Zafari, Z., Albanyan, O., Dairi, M., & FitzGerald, J. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136065 · Cited by 296
Trevisan, C., Veronese, N., Maggi, S., Baggio, G., Toffanello, E. D., Zambon, S., Sartori, L., Musacchio, E., Perissinotto, E., Crepaldi, G., et al. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14515 · Cited by 258
Relationship between polypharmacy and underprescribing
Kuijpers, M. A. J., Van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., & The OLDY (OLd people Drugs & dYsregulations) study group (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02961.x · Cited by 253
Medication prescribing in frail older people
Hubbard, R. E., O’Mahony, M. S., & Woodhouse, K. W. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1387-2 · Cited by 229
Jung, H.-W., Yoo, H.-J., Park, S.-Y., Kim, S.-W., Choi, J.-Y., Yoon, S.-J., Kim, C.-H., & Kim, K.-I. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.331 · Cited by 217
Herr, M., Robine, J.-M., Pinot, J., Arvieu, J.-J., & Ankri, J. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3772 · Cited by 215
Perera, V., Bajorek, B. V., Matthews, S., & Hilmer, S. N. (2008) · Age and Ageing · doi:10.1093/ageing/afn293 · Cited by 204
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study
Saum, K., Schöttker, B., Meid, A. D., Holleczek, B., Haefeli, W. E., Hauer, K., & Brenner, H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14718 · Cited by 203
Veronese, N., Stubbs, B., Noale, M., Solmi, M., Pilotto, A., Vaona, A., Demurtas, J., Mueller, C., Huntley, J., Crepaldi, G., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.009 · Cited by 194
The Relationship Between Number of Medications and Weight Loss or Impaired Balance in Older Adults
Agostini, J. V., Han, L., & Tinetti, M. E. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52467.x · Cited by 167
Merchant, R. A., Chen, M. Z., Tan, L. W. L., Lim, M. Y., Ho, H. K., & van Dam, R. M. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.04.020 · Cited by 163
Bennett, A., Gnjidic, D., Gillett, M., Carroll, P., Matthews, S. T., Johnell, K., Fastbom, J., & Hilmer, S. N. (2014) · Drugs & Aging · doi:10.1007/s40266-013-0151-3 · Cited by 156
A Physiologic Index of Comorbidity: Relationship to Mortality and Disability
Newman, A. B., Boudreau, R. M., Naydeck, B. L., Fried, L. F., & Harris, T. B. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.6.603 · Cited by 152
Gómez, C., Quiroga, S. V., Bermejo‐Pareja, F., Medrano, M. J., Louis, E. D., & Benito‐León, J. (2014) · Gerontology · doi:10.1159/000365328 · Cited by 147
Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study
Ballew, S. H., Chen, Y., Daya, N. R., Godino, J., Windham, B. G., McAdams‐DeMarco, M., Coresh, J., Selvin, E., & Grams, M. E. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.08.034 · Cited by 135
Bonaga, B., Sánchez‐Jurado, P. M., Martínez-Reig, M., Ariza‐Zafra, G., Rodríguez‐Mañas, L., Gnjidic, D., Salvador, T., & Abizanda, P. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.07.008 · Cited by 131
Sumukadas, D., McMurdo, M. E. T., Mangoni, A. A., & Guthrie, B. (2013) · Age and Ageing · doi:10.1093/ageing/aft199 · Cited by 122
Jamsen, K. M., Bell, J. S., Hilmer, S. N., Kirkpatrick, C. M. J., Ilomäki, J., Couteur, D. G. L., Blyth, F., Handelsman, D. J., Waite, L. M., Naganathan, V., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13877 · Cited by 121
Wang, R., Chen, L., Fan, L. H., Gao, D., Liang, Z., He, J., Gong, W., & Gao, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142123 · Cited by 118
Crentsil, V., Ricks, M. O., Xue, Q., & Fried, L. P. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.06.003 · Cited by 115
Herr, M., Sirven, N., Grondin, H., Pichetti, S., & Sermet, C. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2276-5 · Cited by 109
Cullinan, S., O’Mahony, D., O’Sullivan, D., & Byrne, S. (2015) · Age and Ageing · doi:10.1093/ageing/afv166 · Cited by 106
Zheng, Z., Guan, S., Ding, H., Wang, Z., Zhang, J., Zhao, J., Ma, J., & Chan, P. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14135 · Cited by 102
Woo, J., & Leung, J. C. S. (2013) · AGE · doi:10.1007/s11357-013-9590-3 · Cited by 92
Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients
Poudel, A., Peel, N. M., Nissen, L. M., Mitchell, C., Gray, L., & Hubbard, R. E. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.05.017 · Cited by 90
Prescribing for frail older people
Hilmer, S. N., & Gnjidic, D. (2017) · Australian Prescriber · doi:10.18773/austprescr.2017.055 · Cited by 89
Determinants of frailty: the added value of assessing medication
Coelho, T., Paúl, C., Gobbens, R. J. J., & Fernandes, L. P. N. S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00056 · Cited by 79
Adverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of Aging
Huizer‐Pajkos, A., Kane, A. E., Howlett, S. E., Mach, J., Mitchell, S. J., de Cabo, R., Couteur, D. G. L., & Hilmer, S. N. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv046 · Cited by 75
Gentamicin pharmacokinetics in old age and frailty
Hilmer, S. N., Tran, K., Rubie, P., Wright, J., Gnjidic, D., Mitchell, S. J., Matthews, S. T., & Carroll, P. R. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03825.x · Cited by 58
Potential Contribution of Medications to Frailty
Gnjidic, D., & Hilmer, S. N. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03810.x · Cited by 57
Exposure to Atropinic Drugs and Frailty Status
Moulis, F., Moulis, G., Balardy, L., Gérard, S., Montastruc, F., Sourdet, S., Bugat, M.-È. R., Lapeyre‐Mestre, M., Montastruc, J., Rolland, Y., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.017 · Cited by 56
Searching for a Polypharmacy Threshold Associated With Frailty
Moulis, F., Moulis, G., Balardy, L., Gérard, S., Sourdet, S., Bugat, M.-È. R., Lapeyre‐Mestre, M., Montastruc, J., Rolland, Y., & Vellas, B. J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.016 · Cited by 56
Martínez‐Velilla, N., Herce, P. A., Herrero, Á. C., Gutiérrez‐Valencia, M., de Asteasu, M. L. S., Mateos, A. S., Zubillaga, A. C., Ibáñez, B., Galbete, A., & Izquierdo, M. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.016 · Cited by 40
Self-citationHasan, S. S., Kow, C. S., Verma, R. K., Ahmed, S. I., Mittal, P., & Chong, D. W. K. (2017) · Medicine · doi:10.1097/md.0000000000007929 · Cited by 39
Thai, M., Hilmer, S. N., Pearson, S., Reeve, E., & Gnjidic, D. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0302-9 · Cited by 29
Navalón, C. I., Urbieta‐Sanz, E., & Gascón–Cánovas, J. J. (2011) · Revista Clínica Española · doi:10.1016/j.rce.2011.04.005 · Cited by 22
Palmer, K., Marengoni, A., RUSSO, P., Mammarella, F., & Onder, G. (2016) · The Journal of Frailty & Aging · doi:10.14283/jfa.2016.84 · Cited by 15
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
An overview of prevalence, determinants and health outcomes of polypharmacy
Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620933741 · Cited by 443
Association between oral health and frailty: A systematic review of longitudinal studies
Hakeem, F. F., Bernabé, E., & Sabbah, W. (2019) · Gerodontology · doi:10.1111/ger.12406 · Cited by 333
Adverse drug reactions in older adults: a narrative review of the literature
Zazzara, M. B., Palmer, K., Vetrano, D. L., Carfì, A., & Onder, G. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00481-9 · Cited by 283
Metadata
- Authors
- Gutiérrez‐Valencia, M., Izquierdo, M., Cesari, M., Casas‐Herrero, Á., Inzitari, M., & Martínez‐Velilla, N.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2018-05-03
- Volume
- 84
- Issue
- 7
- Pages
- 1432-1444
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2794077735
- Cited by
- 480
- References
- 60
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.